Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Regulatory Science/The Science Board/Standard Development

JP Drafts (March 2023) No.2

JP drafts for public comments, March 1, 2023 - May 31, 2023

New monographs 
New monographs (Crude drug)
Ultraviolet-visible reference spectra
Infrared reference spectra
 

To send the comment on these drafts, the guidance is as follows:

  1. Download the form for comments in  Word format
  2. Fill in the form
  3. Prepare and attach the supportive data that scientifically validate the comment when appropriate
  4. Send it to the email address: JPdraft-engpmda.go.jp

Note:
For the purpose of security, this email address is partly incorrect. Please replace with @ when sending an email.

Related Information

 

Note:
The information submitted with the comments may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).
Your comments will be considered for the preparation of JP final drafts, but no individual response will be made to each comment.